Search Results 221-230 of 17367 for GLP-1 secretion
The objective for thisstudy is to characterize the impact of glycemic excursions on cognition in Type 1 Diabetes (T1D) and determine mediators and moderators of ...
The purpose of this study is to determine feasibility of establishing a T1D screening process for a general clinic population. Participation eligibility.
Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. Staff skilled in dozens ...
The purpose of this study is to evaluate molecular markers which might be a predictor of pancreatic cancer or precancer by analyzing the secretions (fluid) from ...
Mayo Clinic researchers have developed a genetic test that can help predict how people will respond to weight loss medications such as GLP-1s. Latest ...
* Subjects in the non-pancreatic disease subgroup (i.e., T2DM) on longer acting agents, including thiazolidinediones and once-weekly GLP-1 agonists ...
... 1 trial. ... may be discontinued for four half lives prior to study assessments. - Treatment with GLP-1 agonists and amlyin which cause vagal blockade and may ...
Type 1 —This form of diabetes occurs when the pancreas makes very little or no insulin. Type 1 dia- betes is an autoimmune disease that most often develops ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.